ReP USP - Resultado da busca

Artigo de periodico
Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy (2021)
Mori, Augusto Akira ; Castro, Lara Reinel de; Bortolin, Raul Hernandes ; Bastos, Gisele Medeiros; Oliveira, Victor Fernandes de ; Ferreira, Glaucio Monteiro ; Hirata, Thiago Dominguez Crespo ; Fajardo, Cristina Moreno ; Sampaio, Marcelo Ferraz; Moreira, Dalmo Antonio Ribeiro ; Mateos, José Carlos Pachon; Correia, Edileide de Barros; Sousa, Amanda Guerra de Moraes Rego ; Brion, Maria ; Carracedo, Angel ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Forensic Science International. Unidades: FCF, IDPC
Subjects: MORTE SÚBITA, HIPERTROFIA VENTRICULAR ESQUERDA, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORI, Augusto Akira et al. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy. Forensic Science International, v. 52, p. 1-10 art. 102478, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.fsigen.2021.102478. Acesso em: 31 out. 2024.
APA
Mori, A. A., Castro, L. R. de, Bortolin, R. H., Bastos, G. M., Oliveira, V. F. de, Ferreira, G. M., et al. (2021). Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy. Forensic Science International, 52, 1-10 art. 102478. doi:10.1016/j.fsigen.2021.102478
NLM
Mori AA, Castro LR de, Bortolin RH, Bastos GM, Oliveira VF de, Ferreira GM, Hirata TDC, Fajardo CM, Sampaio MF, Moreira DAR, Mateos JCP, Correia E de B, Sousa AG de MR, Brion M, Carracedo A, Hirata RDC, Hirata MH. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy [Internet]. Forensic Science International. 2021 ; 52 1-10 art. 102478.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.fsigen.2021.102478
Vancouver
Mori AA, Castro LR de, Bortolin RH, Bastos GM, Oliveira VF de, Ferreira GM, Hirata TDC, Fajardo CM, Sampaio MF, Moreira DAR, Mateos JCP, Correia E de B, Sousa AG de MR, Brion M, Carracedo A, Hirata RDC, Hirata MH. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy [Internet]. Forensic Science International. 2021 ; 52 1-10 art. 102478.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.fsigen.2021.102478
Trabalho de evento-resumo
Variações genéticas na CYP2C19, CYP2C9, CYP5A1 e ITGA2 associadas com falta de resposta ao clopidogrel (2017)
Luchessi, André Ducati; Brión, Maria; Silbiger, Vivian Nogueira; Bortolin, Raul Hernandes; De Freitas, Renata Caroline Costa; Iñiguez, Andres; Bravo, Marisol; Bastos, Guillermo; Hirata, Rosario Dominguez Crespo ; Carracedo, Angel; Hirata, Mario Hiroyuki
Source: Resumos. Conference titles: Congresso Brasileiro de Cardiologia. Unidade: FCF
Assunto: VARIAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUCHESSI, André Ducati et al. Variações genéticas na CYP2C19, CYP2C9, CYP5A1 e ITGA2 associadas com falta de resposta ao clopidogrel. 2017, Anais.. São Paulo: Sociedade Brasileira de Cardiologia, 2017. . Acesso em: 31 out. 2024.
APA
Luchessi, A. D., Brión, M., Silbiger, V. N., Bortolin, R. H., De Freitas, R. C. C., Iñiguez, A., et al. (2017). Variações genéticas na CYP2C19, CYP2C9, CYP5A1 e ITGA2 associadas com falta de resposta ao clopidogrel. In Resumos. São Paulo: Sociedade Brasileira de Cardiologia.
NLM
Luchessi AD, Brión M, Silbiger VN, Bortolin RH, De Freitas RCC, Iñiguez A, Bravo M, Bastos G, Hirata RDC, Carracedo A, Hirata MH. Variações genéticas na CYP2C19, CYP2C9, CYP5A1 e ITGA2 associadas com falta de resposta ao clopidogrel. Resumos. 2017 ;[citado 2024 out. 31 ]
Vancouver
Luchessi AD, Brión M, Silbiger VN, Bortolin RH, De Freitas RCC, Iñiguez A, Bravo M, Bastos G, Hirata RDC, Carracedo A, Hirata MH. Variações genéticas na CYP2C19, CYP2C9, CYP5A1 e ITGA2 associadas com falta de resposta ao clopidogrel. Resumos. 2017 ;[citado 2024 out. 31 ]
Artigo de periodico
ABCC3 Polymorphisms and mRNA expression influence the concentration of a carboxylic acid metabolite in patients on clopidogrel and aspirin therapy (2017)
Luchessi, André Ducati; Concheiro, Marta; Germano, Juliana de Freitas; Silbiger, Vivian Nogueira; Bortolin, Raul Hernandes; Cruz, Angelines; Quintela, Oscar; Brion, Maria; Carracedo, Angel; Iñiguez, Andres; Bravo, Marisol; Rivadulla, Manuel López; Hirata, Rosario Dominguez Crespo ; Sousa, Amanda Guerra de Moraes Rego; Hirata, Mario Hiroyuki
Source: Basic & Clinical Pharmacology & Toxicology. Unidade: FCF
Subjects: POLIMORFISMO, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUCHESSI, André Ducati et al. ABCC3 Polymorphisms and mRNA expression influence the concentration of a carboxylic acid metabolite in patients on clopidogrel and aspirin therapy. Basic & Clinical Pharmacology & Toxicology, v. 120 p. 466-474, 2017Tradução . . Disponível em: https://doi.org/10.1111/bcpt.12703. Acesso em: 31 out. 2024.
APA
Luchessi, A. D., Concheiro, M., Germano, J. de F., Silbiger, V. N., Bortolin, R. H., Cruz, A., et al. (2017). ABCC3 Polymorphisms and mRNA expression influence the concentration of a carboxylic acid metabolite in patients on clopidogrel and aspirin therapy. Basic & Clinical Pharmacology & Toxicology, 120 p. 466-474. doi:10.1111/bcpt.12703
NLM
Luchessi AD, Concheiro M, Germano J de F, Silbiger VN, Bortolin RH, Cruz A, Quintela O, Brion M, Carracedo A, Iñiguez A, Bravo M, Rivadulla ML, Hirata RDC, Sousa AG de MR, Hirata MH. ABCC3 Polymorphisms and mRNA expression influence the concentration of a carboxylic acid metabolite in patients on clopidogrel and aspirin therapy [Internet]. Basic & Clinical Pharmacology & Toxicology. 2017 ; 120 p. 466-474[citado 2024 out. 31 ] Available from: https://doi.org/10.1111/bcpt.12703
Vancouver
Luchessi AD, Concheiro M, Germano J de F, Silbiger VN, Bortolin RH, Cruz A, Quintela O, Brion M, Carracedo A, Iñiguez A, Bravo M, Rivadulla ML, Hirata RDC, Sousa AG de MR, Hirata MH. ABCC3 Polymorphisms and mRNA expression influence the concentration of a carboxylic acid metabolite in patients on clopidogrel and aspirin therapy [Internet]. Basic & Clinical Pharmacology & Toxicology. 2017 ; 120 p. 466-474[citado 2024 out. 31 ] Available from: https://doi.org/10.1111/bcpt.12703
Artigo de periodico
Pharmacogenomics of anti-platelet therapy focused on peripheral blood cells of coronary arterial disease patients (2013)
Luchessi, André Ducati; Silbiger, Vivian Nogueira; Hirata, Rosario Dominguez Crespo ; Lima Neto, Lidio Gonçalves; Cavichioli, Débora; Iñiguez, Andres; Bravo, Marisol; Bastos, Guillermo; Sousa, Amanda Guerra de Moraes Rego; Brión, Maria; Carracedo, Angel; Hirata, Mario Hiroyuki
Source: Clinica Chimica Acta. Unidade: FCF
Subjects: DOENÇAS CARDIOVASCULARES, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUCHESSI, André Ducati et al. Pharmacogenomics of anti-platelet therapy focused on peripheral blood cells of coronary arterial disease patients. Clinica Chimica Acta, v. 425, p. 9-17, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2013.06.021. Acesso em: 31 out. 2024.
APA
Luchessi, A. D., Silbiger, V. N., Hirata, R. D. C., Lima Neto, L. G., Cavichioli, D., Iñiguez, A., et al. (2013). Pharmacogenomics of anti-platelet therapy focused on peripheral blood cells of coronary arterial disease patients. Clinica Chimica Acta, 425, 9-17. doi:10.1016/j.cca.2013.06.021
NLM
Luchessi AD, Silbiger VN, Hirata RDC, Lima Neto LG, Cavichioli D, Iñiguez A, Bravo M, Bastos G, Sousa AG de MR, Brión M, Carracedo A, Hirata MH. Pharmacogenomics of anti-platelet therapy focused on peripheral blood cells of coronary arterial disease patients [Internet]. Clinica Chimica Acta. 2013 ; 425 9-17.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.cca.2013.06.021
Vancouver
Luchessi AD, Silbiger VN, Hirata RDC, Lima Neto LG, Cavichioli D, Iñiguez A, Bravo M, Bastos G, Sousa AG de MR, Brión M, Carracedo A, Hirata MH. Pharmacogenomics of anti-platelet therapy focused on peripheral blood cells of coronary arterial disease patients [Internet]. Clinica Chimica Acta. 2013 ; 425 9-17.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.cca.2013.06.021
Artigo de periodico
Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response (2013)
Rodrigues, Alice Cristina ; Sobrino, B; Genvigir, Fabiana Dalla Vecchia; Willrich, Maria Alice Vieira; Arazi, Simone Sorkin; Dórea, Egidio Lima; Bernik, Marcia Martins Silveira; Bertolami, Marcelo; Faludi, André Arpad; Brion, M. J; Carracedo, Angel; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Clinica Chimica Acta. Unidades: HU, FCF
Subjects: DISLIPIDEMIAS, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Alice Cristina et al. Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response. Clinica Chimica Acta, v. 417, n. 1, p. 8-11, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2012.11.028. Acesso em: 31 out. 2024.
APA
Rodrigues, A. C., Sobrino, B., Genvigir, F. D. V., Willrich, M. A. V., Arazi, S. S., Dórea, E. L., et al. (2013). Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response. Clinica Chimica Acta, 417( 1), 8-11. doi:10.1016/j.cca.2012.11.028
NLM
Rodrigues AC, Sobrino B, Genvigir FDV, Willrich MAV, Arazi SS, Dórea EL, Bernik MMS, Bertolami M, Faludi AA, Brion MJ, Carracedo A, Hirata MH, Hirata RDC. Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response [Internet]. Clinica Chimica Acta. 2013 ; 417( 1): 8-11.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.cca.2012.11.028
Vancouver
Rodrigues AC, Sobrino B, Genvigir FDV, Willrich MAV, Arazi SS, Dórea EL, Bernik MMS, Bertolami M, Faludi AA, Brion MJ, Carracedo A, Hirata MH, Hirata RDC. Genetic variants in genes related to lipid metabolism and atherosclerosis, dyslipidemia and atorvastatin response [Internet]. Clinica Chimica Acta. 2013 ; 417( 1): 8-11.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.cca.2012.11.028
Artigo de periodico
Increased clopidogrel response is associated with ABCC3 expression: a pilot study (2012)
Luchessi, André Ducati; Silbiger, Vivian Nogueira; Cerda, Alvaro; Hirata, Rosario Dominguez Crespo ; Carracedo, Angel; Brion, Maria; Iñiguez, Andres; Bravo, Marisol; Bastos, Guillermo; Sousa, Amanda Guerra de Moraes Rego; Hirata, Mario Hiroyuki
Source: Clinica Chimica Acta. Unidade: FCF
Subjects: EXPRESSÃO GÊNICA, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUCHESSI, André Ducati et al. Increased clopidogrel response is associated with ABCC3 expression: a pilot study. Clinica Chimica Acta, v. 413, n. 3-4, p. 417-421, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.cca.2011.10.018. Acesso em: 31 out. 2024.
APA
Luchessi, A. D., Silbiger, V. N., Cerda, A., Hirata, R. D. C., Carracedo, A., Brion, M., et al. (2012). Increased clopidogrel response is associated with ABCC3 expression: a pilot study. Clinica Chimica Acta, 413( 3-4), 417-421. doi:10.1016/j.cca.2011.10.018
NLM
Luchessi AD, Silbiger VN, Cerda A, Hirata RDC, Carracedo A, Brion M, Iñiguez A, Bravo M, Bastos G, Sousa AG de MR, Hirata MH. Increased clopidogrel response is associated with ABCC3 expression: a pilot study [Internet]. Clinica Chimica Acta. 2012 ; 413( 3-4): 417-421.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.cca.2011.10.018
Vancouver
Luchessi AD, Silbiger VN, Cerda A, Hirata RDC, Carracedo A, Brion M, Iñiguez A, Bravo M, Bastos G, Sousa AG de MR, Hirata MH. Increased clopidogrel response is associated with ABCC3 expression: a pilot study [Internet]. Clinica Chimica Acta. 2012 ; 413( 3-4): 417-421.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.cca.2011.10.018
Artigo de periodico
Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response (2011)
Rodrigues, Alice Cristina ; Perin, Paula Monteiro dos Santos; Purim, Sheila Gregório; Silbiger, Vivian Nogueira; Genvigir, Fabiana Dalla Vecchia; Willrich, Maria Alice Vieira; Arazi, Simone Sorkin; Luchessi, André Ducati; Hirata, Mario Hiroyuki ; Bernik, Marcia Martins Silveira; Dórea, Egidio Lima; Santos, Carla; Faludi, André A; Bertolami, Marcelo C; Salas, Antonio; Freire, Ana; Lareu, Maria V; Phillips, Christopher; Porras-Hurtado, Liliana; Fondevila, Manuel; Carracedo, Angel; Hirata, Rosario Dominguez Crespo
Source: International Journal of Molecular Sciences. Unidades: FCF, HU
Subjects: FARMACOTÉCNICA, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Alice Cristina et al. Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response. International Journal of Molecular Sciences, v. 12, p. 5815-5827, 2011Tradução . . Disponível em: https://doi.org/10.3390/ijms12095815. Acesso em: 31 out. 2024.
APA
Rodrigues, A. C., Perin, P. M. dos S., Purim, S. G., Silbiger, V. N., Genvigir, F. D. V., Willrich, M. A. V., et al. (2011). Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response. International Journal of Molecular Sciences, 12, 5815-5827. doi:10.3390/ijms12095815
NLM
Rodrigues AC, Perin PM dos S, Purim SG, Silbiger VN, Genvigir FDV, Willrich MAV, Arazi SS, Luchessi AD, Hirata MH, Bernik MMS, Dórea EL, Santos C, Faludi AA, Bertolami MC, Salas A, Freire A, Lareu MV, Phillips C, Porras-Hurtado L, Fondevila M, Carracedo A, Hirata RDC. Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response [Internet]. International Journal of Molecular Sciences. 2011 ; 12 5815-5827.[citado 2024 out. 31 ] Available from: https://doi.org/10.3390/ijms12095815
Vancouver
Rodrigues AC, Perin PM dos S, Purim SG, Silbiger VN, Genvigir FDV, Willrich MAV, Arazi SS, Luchessi AD, Hirata MH, Bernik MMS, Dórea EL, Santos C, Faludi AA, Bertolami MC, Salas A, Freire A, Lareu MV, Phillips C, Porras-Hurtado L, Fondevila M, Carracedo A, Hirata RDC. Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response [Internet]. International Journal of Molecular Sciences. 2011 ; 12 5815-5827.[citado 2024 out. 31 ] Available from: https://doi.org/10.3390/ijms12095815

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Non normalized affiliation